Literature DB >> 11559648

Human gastric B cell responses can be induced by intestinal immunisation.

M Quiding-Järbrink1, H Lönroth, I Ahlstedt, J Holmgren, A M Svennerholm.   

Abstract

BACKGROUND: In a previous study, we found that oral vaccination induces strong B cell responses in the stomach of Helicobacter pylori infected but not of uninfected individuals. In this study, we have evaluated the possibility of inducing gastric immune responses in H pylori infected volunteers by intestinal and gastric immunisation.
METHODS: H pylori infected subjects were given two doses of an inactivated cholera vaccine, either intestinally via an endoscope approximately 30 cm distal to the pylorus sphincter or intragastrically as small droplets applied directly onto the stomach mucosa. Uninfected individuals received the vaccine by standard oral procedure. Vaccine specific antibody secreting cells in antral and duodenal biopsies were detected by the enzyme linked immunospot assay technique before and seven days after the second immunisation.
RESULTS: Intestinal immunisations resulted in induction of vaccine specific gastric IgA secreting cells in five of eight volunteers. This immunisation schedule also gave rise to specific duodenal antibody secreting cells in seven of eight individuals. Local gastric immunisation resulted in the induction of specific B cells in the gastric mucosa of four of eight volunteers. Gastric antigen application also resulted in B cell responses in the duodenum in all volunteers. Uninfected volunteers receiving the vaccine perorally responded in the duodenum but not in the stomach.
CONCLUSIONS: H pylori infection increases the ability of the gastric mucosa to serve as an expression site for intestinally induced B cell responses. These findings are of importance when designing a therapeutic H pylori vaccine, and based on our results such a vaccine can be delivered along the whole upper gastrointestinal tract.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11559648      PMCID: PMC1728478          DOI: 10.1136/gut.49.4.512

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  52 in total

1.  Anatomic segmentation of the intestinal immune response in nonhuman primates: differential distribution of B cells after oral and rectal immunizations to sites defined by their source of vascularization.

Authors:  K Eriksson; M Quiding-Järbrink; J Osek; I Nordström; M Hjulström; J Holmgren; C Czerkinsky
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

2.  Safety and immunogenicity of an oral recombinant cholera B subunit-whole cell vaccine in Swedish volunteers.

Authors:  M Jertborn; A M Svennerholm; J Holmgren
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

3.  A novel two colour ELISPOT assay. I. Simultaneous detection of distinct types of antibody-secreting cells.

Authors:  C Czerkinsky; Z Moldoveanu; J Mestecky; L A Nilsson; O Ouchterlony
Journal:  J Immunol Methods       Date:  1988-11-25       Impact factor: 2.303

Review 4.  The common mucosal immune system and current strategies for induction of immune responses in external secretions.

Authors:  J Mestecky
Journal:  J Clin Immunol       Date:  1987-07       Impact factor: 8.317

5.  Chemokine mRNA expression in gastric mucosa is associated with Helicobacter pylori cagA positivity and severity of gastritis.

Authors:  T Shimoyama; S M Everett; M F Dixon; A T Axon; J E Crabtree
Journal:  J Clin Pathol       Date:  1998-10       Impact factor: 3.411

6.  Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory.

Authors:  M Quiding; I Nordström; A Kilander; G Andersson; L A Hanson; J Holmgren; C Czerkinsky
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

7.  Immune response of the gastric mucosa to Campylobacter pylori.

Authors:  J I Wyatt; B J Rathbone
Journal:  Scand J Gastroenterol Suppl       Date:  1988

8.  Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis.

Authors:  J E Crabtree; T M Shallcross; R V Heatley; J I Wyatt
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

9.  Tissue distribution of mucosal antibody-producing cells specific for respiratory syncytial virus in severe combined immune deficiency (SCID) mice engrafted with human tonsils.

Authors:  D Nadal; B Albini; E Schläpfer; C Chen; L Brodsky; P L Ogra
Journal:  Clin Exp Immunol       Date:  1991-09       Impact factor: 4.330

10.  Serologic differentiation between antitoxin responses to infection with Vibrio cholerae and enterotoxin-producing Escherichia coli.

Authors:  A M Svennerholm; J Holmgren; R Black; M Levine; M Merson
Journal:  J Infect Dis       Date:  1983-03       Impact factor: 5.226

View more
  6 in total

1.  Homing commitment of lymphocytes activated in the human gastric and intestinal mucosa.

Authors:  M Quiding-Järbrink; I Ahlstedt; C Lindholm; E L Johansson; H Lönroth
Journal:  Gut       Date:  2001-10       Impact factor: 23.059

2.  Protection against experimental Helicobacter pylori infection after immunization with inactivated H. pylori whole-cell vaccines.

Authors:  S Raghavan; M Hjulström; J Holmgren; A-M Svennerholm
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

3.  CCL28 is increased in human Helicobacter pylori-induced gastritis and mediates recruitment of gastric immunoglobulin A-secreting cells.

Authors:  Malin Hansson; Michael Hermansson; Helena Svensson; Anders Elfvin; Lars-Erik Hansson; Erik Johnsson; Asa Sjöling; Marianne Quiding-Järbrink
Journal:  Infect Immun       Date:  2008-04-21       Impact factor: 3.441

4.  Effects of oral vaccination and immunomodulation by cholera toxin on experimental Helicobacter pylori infection, reinfection, and gastritis.

Authors:  S Raghavan; A-M Svennerholm; J Holmgren
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

5.  Selective upregulation of endothelial E-selectin in response to Helicobacter pylori-induced gastritis.

Authors:  Helena Svensson; Malin Hansson; Jan Kilhamn; Steffen Backert; Marianne Quiding-Järbrink
Journal:  Infect Immun       Date:  2009-05-04       Impact factor: 3.441

6.  The frequency of circulating integrin α4β7+ cells correlates with protection against Helicobacter pylori infection in immunized mice.

Authors:  Sarmin Akter; Frida Jeverstam; Anna Lundgren; Maria K Magnusson; Anna Walduck; Firdausi Qadri; Taufiqur Rahman Bhuiyan; Sukanya Raghavan
Journal:  Helicobacter       Date:  2019-09-09       Impact factor: 5.753

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.